AIM ImmunoTech Inc. - AIM Real Price to Acquire Entire Company
AIM ImmunoTech specializes in developing the unique immunomodulator Ampligen to combat oncology and chronic fatigue, which enables the company to maintain premium pricing. Strategic alliances with medical centers and joint research in virology enhance the asset's attractiveness for future mergers. The market value dynamics of the asset at 0.49 reflect the impact of high R&D costs and a lack of operating leverage during the expansion of testing.
Analytical breakdowns for AIM ImmunoTech
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:AIM (AIM ImmunoTech, Inc.)
Enterprise value combines market capitalization with net debt, reflecting the total acquisition cost of the business minus available cash. By analyzing the indicative enterprise value level, an investor can assess whether the rental income from the exclusive drug Ampligen justifies the current market value of AIM ImmunoTech (AIM), confirming the company's fundamental stability.
Who AIM ImmunoTech competes with
argenx N.V. - Company Buyout Price|BNTX: Total Company Value|ABVX: Real Price to Acquire Entire Company|Total Company Value ADMA Biologics (ADMA)|protagonist-inc.com (PTGX) - Full Business Value|IMVT - Enterprise Value|Value Adjusted for Debt and Cash Kiniksa Pharmaceuticals, Ltd.|Enterprise Value GRFS|Enterprise Value ADPT (Adaptive Biotechnologies Inc.)|Total Company Value Celldex Therapeutics|auriniapharma.com - Value Adjusted for Debt and Cash|BCRX: Total Company Value|VERA - Real Price to Acquire Entire Company|DNTH: Enterprise Value|Enterprise Value Pharvaris Pharma|ABCL - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash tourmalinebio.com|PGEN (Precigen) - Enterprise Value|Company Buyout Price PHAR (Pharming Group NV)|Nektar - Total Company Value|Upstream Pharma - Real Price to Acquire Entire Company|ZBIO: Total Company Value|immunome.com (IMNM) - Real Price to Acquire Entire Company|GOSS: Real Price to Acquire Entire Company|KALV (KalVista Pharma) - Enterprise Value|Total Company Value Septerna Corp (SEPN)|Business Value Pieris Corp|Savara Inc. - Enterprise Value|Total Enterprise Value rigel.com (RIGL)|Enterprise Value ANAB (AnaptysBio)|Enterprise Value Astria Therapeutics Inc ATXS|Enterprise Value ENGN (enGene Bio)|RAPT: Company Buyout Price|JBIO (aerovatetx.com) - Total Company Value|Real Price to Acquire Entire Company aclaristx.com|KYTX - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Tiziana Life Sciences Ltd.|CABA (Cabaletta Bio, Inc) - Enterprise Value|Company Buyout Price VTYX (Ventyx Biosciences, Inc)|Theratechnologies Inc. - Total Company Value|avalotx.com - Real Price to Acquire Entire Company|ELDN: Total Company Value|Agenus, Inc. (AGEN) - Real Price to Acquire Entire Company|CLYM: Real Price to Acquire Entire Company|ZURA (Zura Bio Ltd) - Enterprise Value|Total Company Value aTyr Pharma, Inc. (ATYR)|Business Value ADAG|ImageneBio Inc - Total Company Value|Total Enterprise Value shattucklabs.com STTK|Real Price to Acquire Entire Company Equillium (EQ)|Aggregate Business Value Connect Biopharma Holdings CNTB|IMUX (Immunic Inc) - Enterprise Value|ATRA - Total Enterprise Value|IFRX (inflarx.de) - Enterprise Value|X4 Pharmaceuticals Inc. (XFOR) - Real Price to Acquire Entire Company|ACET - Enterprise Value|Value Adjusted for Debt and Cash Celularity Corp|Enterprise Value INMB|Enterprise Value barinthusbio.com (BRNS)|Enterprise Value KZR|SAB Biotherapeutics Inc. - Company Buyout Price|AKTX: Total Company Value|ENLV: Real Price to Acquire Entire Company|Total Company Value q32bio.com (QTTB)|geovax.com (GOVX) - Full Business Value|EDSA - Enterprise Value|Value Adjusted for Debt and Cash iBio Inc|Enterprise Value CARM|Enterprise Value XTLB (XTL Bio)|Total Company Value Bolt Biotherapeutics, Inc.|HCW Biologics, Inc. - Value Adjusted for Debt and Cash|APVO: Total Company Value|ADTX - Real Price to Acquire Entire Company|GRI: Enterprise Value|Enterprise Value XORTX Corp|HIND - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash revbiosciences.com|INDP (Indaptus Therapeutics, Inc.) - Enterprise Value|Company Buyout Price SCNI (Scinai Immunotherapeutics Ltd)|CalciMedica - Total Company Value|Affimed NV - Real Price to Acquire Entire Company|ALLK: Total Company Value|HOOKIPA Pharma Inc. (HOOK) - Real Price to Acquire Entire Company|IGMS: Real Price to Acquire Entire Company|ITOS (iTeos Therapeutics Inc) - Enterprise Value|Total Company Value Ocean Bio (OCEA)|Business Value TC BioPharm Ltd|Third Harmonic Bio - Enterprise Value